Metabolomics/Nutrition/Vitamin D

Vitamin D is a group of fat-soluble secosteroids, the two major physiologically relevant forms of which are vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol). Vitamin D without a subscript refers to either D2 or D3 or both. Vitamin D is produced in the skin of vertebrates after exposure to ultraviolet B light, and occurs naturally in a small range of foods. In some countries staples such as milk, flour and margarine are artificially fortified with vitamin D, and it is also available as a supplement in pill form.[2]

W:Cholecalciferol (D3)
Calcium regulation in the human body.[1] The role of vitamin D is shown in orange.

Vitamin D is carried in the bloodstream to the liver, where it is converted into the prohormone calcidiol. Circulating calcidiol may then be converted into calcitriol, the biologically active form of vitamin D, either in the kidneys or by monocyte-macrophages in the immune system. When synthesized by monocyte-macrophages, calcitriol acts locally as a cytokine, defending the body against microbial invaders.[3]

When synthesized in the kidneys, calcitriol circulates as a hormone, regulating, among other things, the concentration of calcium and phosphate in the bloodstream, promoting the healthy mineralization, growth and remodeling of bone, and the prevention of hypocalcemic tetany. Vitamin D insufficiency can result in thin, brittle, or misshapen bones, while sufficiency prevents rickets in children and osteomalacia in adults, and, together with calcium, helps to protect older adults from osteoporosis. Vitamin D also modulates neuromuscular function, reduces inflammation, and influences the action of many genes that regulate the cell proliferation|proliferation, cell differentiation|differentiation and apoptosis of cells.[4]

Forms

edit
Name Chemical composition Structure
Vitamin D1 molecular compound of ergocalciferol with lumisterol, 1:1
Vitamin D2 ergocalciferol (made from ergosterol) File:Ergocalciferol.svg|70px|Note double bond at top center.
Vitamin D3 cholecalciferol (made from 7-dehydrocholesterol in the skin). File:Cholecalciferol.svg|70px
Vitamin D4 22-dihydroergocalciferol File:22-Dihydroergocalciferol.png|70px
Vitamin D5 sitocalciferol (made from 7-dehydrositosterol) File:VitaminD5 structure.png|80px

Several forms (vitamers) of vitamin D have been discovered (see table). The two major forms are vitamin D2 or ergocalciferol, and vitamin D3 or cholecalciferol. These are known collectively as calciferol.[5] Ergocalciferol|Vitamin D2 was chemically characterized in 1932. In 1936 the chemical structure of Cholecalciferol|vitamin D3 was established and resulted from the ultraviolet|ultraviolet irradiation of 7-dehydrocholesterol.[6]

Chemically, the various forms of vitamin D are secosteroids; i.e., steroids in which one of the bonds in the steroid rings is broken.[7] The structural difference between vitamin D2 and vitamin D3 is in their side chains. The side chain of D2 contains a double bond between carbons 22 and 23, and a methyl group on carbon 24.

Vitamin D2 (made from ergosterol) is produced by invertebrates, fungus and plants in response to UV irradiation; it is not produced by vertebrates. Little is known about the biologic function of vitamin D2 in nonvertebrate species. Because ergosterol can more efficiently absorb the ultraviolet radiation that can damage DNA, RNA and protein it has been suggested that ergosterol serves as a sunscreening system that protects organisms from damaging high energy ultraviolet radiation.[8]

Vitamin D3 is made in the skin when 7-dehydrocholesterol reacts with UVB ultraviolet light at wavelengths between 270–300 nm, with peak synthesis occurring between 295-297 nm.[citation needed] These wavelengths are present in sunlight when the UV index is greater than 3. At this solar elevation, which occurs daily within the tropics, daily during the spring and summer seasons in temperate regions, and almost never within the arctic circles, vitamin D3 can be made in the skin. Depending on the concentration of UVB rays and the minutes of exposure, an equilibrium can develop in the skin, and vitamin D degrades as fast as it is generated.[citation needed]

Production in the skin

edit
 
The epidermal strata of the skin. Production is greatest in the stratum basale (colored red in the illustration) and stratum spinosum (colored orange).

The skin consists of two primary layers: the inner layer called the dermis, composed largely of connective tissue, and the outer, thinner epidermis (skin)|epidermis. The epidermis consists of five strata; from outer to inner they are: the stratum corneum, stratum lucidum, stratum granulosum, stratum spinosum, and stratum basale.

Cholecalciferol is produced photochemically in the skin from 7-dehydrocholesterol; 7-dehydrocholesterol is produced in relatively large quantities in the skin of most vertebrate animals, including humans.[9] The naked mole rat appears to be naturally cholecalciferol deficient as serum 25-OH vitamin D levels are undetectable.[10] Interestingly, the naked mole rat is resistant to aging, maintains healthy vascular function[11] and is the longest lived of all rodents.[12]

In some animals, the presence of fur or feathers blocks the UV rays from reaching the skin. In birds and fur-bearing mammals, vitamin D is generated from the oily secretions of the skin deposited onto the fur and obtained orally during grooming.[13]

In 1923, it was established that when 7-Dehydrocholesterol|7-dehydrocholesterol is irradiated with light, a form of a fat-soluble vitamin is produced. Alfred Fabian Hess showed that "light equals vitamin D".[14] Adolf Otto Reinhold Windaus|Adolf Windaus, at the University of Göttingen in Germany, received the Nobel Prize in Chemistry in 1928, for his work on the constitution of sterols and their connection with vitamins.[15] In the 1930s he clarified further the chemical structure of vitamin D.

Human cultures can play a big role in determining sun exposure in their Vitamin D level. For example, Women and children living in Kabul, Afghanistan as well as immigrants in the Netherlands have been limited outdoor time and wear clothing that cover their hands, face, and legs. [16] [17]

Synthesis mechanism (form 3)

edit
photolyzed by ultraviolet light in 6-electron conrotatory electrocyclic reaction. The product is previtamin D3|pre-vitamin D3. 400px
Pre-vitamin D3 then spontaneously isomerizes to Vitamin D3 in a antarafacial hydride [1,7] Sigmatropic shift. At room temperature the transformation of previtamin-D3 to vitamin D3 takes about 12 days to complete.[8] 400px
Whether it is made in the skin or ingested, vitamin D3 (cholecalciferol) is then hydroxylated in the liver to 25-hydroxycholecalciferol (25(OH)D3 or calcidiol) by the enzyme 25-hydroxylase produced by hepatocytes. This hydroxylation reaction occurs in the endoplasmic reticulum and requires NADPH, O2 and Mg2+ yet it is not a cytochrome P450 enzyme. Once made the product is stored in the hepatocytes until it is needed and then can be released into the plasma where it will be bound to an α-globulin.

25-hydroxycholecalciferol is then transported to the proximal tubules of the kidneys where it can be hydroxylated by one of two enzymes to different forms of vitamin D, one of which is active vitamin D (1,25-OH D) and another which is inactive vitamin D (24,25-OH D). The enzyme 1α-hydroxylase which is activated by parathyroid hormone (and additionally by low calcium or phosphate) forms the main biologically active vitamin D hormone with a C1 hydroxylation forming 1,25-dihydroxycholecalciferol (1,25(OH)2D3, also known as calcitriol). A separate enzyme hydroxylates the C24 atom forming 24R,25(OH)2D3 when 1α-hydroxylase is not active, this inactivates the molecule from any biological activity. Calcitriol is represented below right (hydroxylated Carbon 1 is on the lower ring at right, hydroxylated Carbon 25 is at the upper right end).

400px

Mechanism of action

edit

Following the final converting step in the kidney, calcitriol (the physiologically active form of vitamin D) is released into the circulation. By binding to vitamin D-binding protein (VDBP), a carrier protein in the blood plasma|plasma, calcitriol is transported to various target organs.[7]

Calcitriol mediates its biological effects by binding to the vitamin D receptor (VDR), which is principally located in the Cell nucleus|nuclei of target cells.[7] The binding of calcitriol to the VDR allows the VDR to act as a transcription factor that modulates the gene expression of transport proteins (such as TRPV6 and calbindin), which are involved in calcium absorption in the intestine.

The vitamin D receptor belongs to the nuclear receptor superfamily of steroid hormone receptor|steroid/thyroid hormone receptors, and VDRs are expressed by cells in most organ (biology)|organs, including the brain, heart, skin, gonads, prostate, and breast. VDR activation in the intestine, bone, kidney, and parathyroid gland cells leads to the maintenance of calcium and phosphorus levels in the blood (with the assistance of parathyroid hormone and calcitonin) and to the maintenance of bone content.[18]

The VDR is known to be involved in cell proliferation and cellular differentiation|differentiation. Vitamin D also #Role in immunomodulation|affects the immune system, and VDRs are expressed in several white blood cells, including monocytes and activated T cell|T and B cells.[19]

Apart from VDR activation, various alternative mechanisms of action are known. An important one of these is its role as a natural inhibitor of signal transduction by hedgehog signaling pathway|hedgehog (a hormone involved in morphogenesis).[20][21]

Nutrition

edit

Vitamin D is naturally produced by the human body when exposed to direct sunlight. In many countries, such foods as milk, yogurt, margarine, Cooking oil|oil spreads, breakfast cereal, pastries, and bread are food fortification|fortified with vitamin D2 and/or vitamin D3.[22] In the United States and Canada, for example, fortified milk typically provides 100 IU per cup (1 IU is the biological equivalent of 0.025 μg), or a quarter of the estimated adequate intake for adults over age 50.[4][23] In the United States (U.S.), typical diets provide about 100 IU/day. The NIH has set the safe upper limit at 2000 IU/day.[24][25]

The optimal level of 25-hydroxyvitamin D vitamin D in adults is 75–80 nmol/l.[26]

A study by Semira Manaseki-Holland, M. Zulf Mughal, Zulfiqar Bhutta and M. Qasem Shams showed that in developing countries such as Iran, Saudi Arabia, India, China, And Syria children are low on Vitamin D. This is due to lack of fish, eggs , and liver in their diet and a general lack of access to diverse foods. [27] A study showed that the top food sources of vitamin D for Asian women was meat, cereals and eggs. The top food sources of vitamin D in Caucasian women is meat, fish and cereals. The study showed that Caucasian women had a higher overall vitamin D intake. [28]



Natural sources

edit
 
Fatty fish, such as salmon, are natural sources of vitamin D.

Natural sources of vitamin D include:[4]

  • Fatty fish species, such as:
    • Catfish, 85 g (3 oz) provides 425 IU
    • Salmon, cooked, 100 g (3.5 oz) provides 360 IU
    • Mackerel, cooked, 100 g (3.5 oz), 345 IU
    • Sardines, canned in oil, drained, 50 g (1.75 oz), 250 IU
    • Tuna, canned in oil, 100 g (3.5 oz), 235 IU
    • Eel, cooked, 100 g (3.5 oz), 200 IU
  • A whole egg (food)|egg, provides 20 IU
  • Beef liver, cooked, 100 g (3.5 oz), provides 15 IU
  • Fish liver oils, such as cod liver oil, 1 Tablespoon|Tbs. (15 ml) provides 1,360 IU
  • Mushrooms are the only vegan source of vitamin D. (after UV light or sunlight exposure)[29][30]

Measuring vitamin D status

edit

A blood calcidiol (25-hydroxy-vitamin D) level is a satisfactory way to determine the cumulative effect of sun and diet in relation to vitamin D[31] although serum 25(OH)D levels do not indicate the amount of vitamin D stored in other body tissues.[32] In overweight persons increased fat mass is inversely associated with 25OHD levels.[33][34] This association may confound the reported relationships between low vitamin D status and conditions which occur more commonly in obesity[35] as the circulating 25(OH)D underestimates their total body stores.[36] A concentration of over 15 ng/ml (>37.5 nmol/L) is recommended.[citation needed] Higher levels (>30 ng/ml or >75 nmol/L) are proposed by some as desirable for achieving optimum health but there is not enough evidence to support them.[37][38][39][40] A study of highly sun exposed (tanned) heathy young skateboarders and surfers in Hawaii found levels below the proposed higher minimum of 30 ng/ml in 51% of the subjects. The highest 25(OH)D concentration was around 60 ng/ml (150nmol/L).[41] A similar <using the same data> study in Hawaii found a range of (11–71 ng/mL) in a population with prolonged extensive skin exposure while as part of the same study Wisconsin breastfeeding mothers were given supplements. The range of circulating 25(OH)D levels in women in the supplementated group was from 12–77 ng/mL. It is noteworthy that the levels in the supplemented population in Wisconsin were higher than the sun exposed group in Hawaii (which again included surfers because it was the same data set).[42] Vitamin D toxicity is usually the result of taking supplements in excess, when toxic symptoms occur the serum 25(OH)D levels are usually found to be elevated >150 ng/mL (>375 nmol/L).[43]

Deficiency

edit

Low blood calcidiol (25-hydroxy-vitamin D) can result from avoiding the sun although it is also found in those with abundant exposure to bright sunlight.[44] Deficiency results in impaired bone mineralization, and leads to bone softening diseases[45] including:

  • Rickets, a childhood disease characterized by impeded growth, and deformity, of the long bones which can be caused by calcium or phosphorus deficiency as well as a lack of vitamin D; today it is largely found in low income countries in Africa, Asia or the Middle East[46] and in those with genetic disorders such as pseudovitamin D deficiency rickets.[47] Rickets was first described in 1650 by Francis Glisson who said it had first appeared about 30 years previously in the counties of Dorset and Somerset.[48] In 1857 John Snow (physician)|John Snow suggested the rickets then widespread in Britain was being caused by the adulteration of bakers bread with alum.[49] The role of diet in the development of rickets[50][51] was determined by Edward Mellanby between 1918–1920.[52] Nutritional rickets exists in countries with intense year round sunlight such as Nigeria and can occur without vitamin D deficiency.[53][54] Although rickets and osteomalacia are now rare in Britain there have been outbreaks in some immigrant communities in which osteomalacia sufferers included women with seemingly adequate daylight outdoor exposure wearing Western clothing.[55] Having darker skin and reduced exposure to sunshine did not produce rickets unless the diet deviated from a Western omnivore pattern characterized by high intakes of meat, fish and eggs, and low intakes of high-extraction cereals.[56][57][58] The dietary risk factors for rickets include abstaining from animal foods.[59][60] Vitamin D deficiency remains the main cause of rickets among young infants in most countries, because breast milk is low in vitamin D and social customs and climatic conditions can prevent adequate UVB exposure. In sunny countries such as Nigeria, South Africa, and Bangladesh where the disease occurs among older toddlers and children it has been attributed to low dietary calcium intakes, which are characteristic of cereal-based diets with limited access to dairy products.[61] Rickets was formerly a major public health problem among the US population; in Denver where ultraviolet rays are approximately 20% stronger than at sea level on the same latitude[62] almost two thirds of 500 children had mild rickets in the late 1920s.[63] An increase in the proportion of animal protein[60][64] in the 20th century American diet coupled with increased consumption of milk[65][66] fortified with relatively small quantities of vitamin D coincided with a dramatic decline in the number of rickets cases.[18]
  • Osteomalacia, a bone-thinning disorder that occurs exclusively in adults and is characterized by proximal muscle weakness and bone fragility. The effects of osteomalacia are thought to contribute to chronic musculoskeletal pain,[67][68] there is no persuasive evidence of lower vitamin D status in chronic pain sufferers.[69]

There are associations between low 25(OH)D levels and a very wide range of diseases,[70] including several autoimmune diseases.[71][18][72] However such associations were found in observational studies and are not conclusive evidence of a causal link (see correlation does not imply causation); a systemic review[39] found no effect of vitamin D supplements.

One leading[73] proponent of the view that the optimal concentration of 25(OH)D is at least 30 ng/ml[74] defines vitamin D deficiency as a 25(OH)D level of under 20 ng/ml (50 nmol/l); applying this criterion he regards 30% to 50% of the United States population as suffering from vitamin D deficiency.[75] This includes areas with abundant sun exposure, such as Hawaii and southern Arizona, where over 50% of inhabitants have 25(OH)D level of under 20 ng/ml.[76][77] Such metrics[78] depart from more typical definitions of vitamin deficiency, which are based on prevention of overt deficiency symptoms or comparable biologic indicators.[31][79] Still higher levels are advocated by some. It is hypothesized that as humans live today, 25-Hydroxyvitamin D3 1-alpha-hydroxylase operates well below its V(max) because of 'chronic substrate deficiency' and the definitions of “sufficient” includes the criterion that parathyroid hormone levels be not lowered further by increasing 25(OH)D levels. According to this school of thought optimal nutritional vitamin D status is achieved when circulating 25(OH)D exceeded 40 ng/mL (100 nmol/L)[42] However, no study has demonstrated a health benefit for the suggested goal of minimizing PTH levels in normal individuals.[80]

Toxicity

edit

Wikipedia hypervitaminosis D In healthy adults, sustained intake of 1250 micrograms/day (50,000 IU) can produce overt toxicity after several months;[81] those with certain medical conditions are far more sensitive to vitamin D and develop hypercalcaemia in response to any increase in vitamin D nutrition, while maternal hypercalcaemia during pregnancy may increase fetal sensitivity to effects of vitamin D and lead to a syndrome of mental retardation and facial deformities.[82][83] Pregnant or breastfeeding women should consult a doctor before taking a vitamin D supplement. For infants (birth to 12 months) the tolerable Upper Limit (maximum amount that can be tolerated without harm) is set at 25 micrograms/day (1000 IU). 1000 micrograms/day (40,000 IU) in infants has produced toxicity within 1 month.[84] The U.S. Dietary Reference Intake Tolerable Upper Intake Level (upper limit) of vitamin D for children and adults is set at 50 micrograms/day (2,000 IU). Vitamin D overdose causes hypercalcemia and the main symptoms of vitamin D overdose are those of hypercalcemia: anorexia, nausea, and vomiting can occur, frequently followed by polyuria, polydipsia, weakness, nervousness, pruritus, and ultimately, renal failure. Proteinuria, urinary casts, azotemia, and metastatic calcification (especially in the kidneys) may develop.[85] Vitamin D toxicity is treated by discontinuing vitamin D supplementation and restricting calcium intake. Kidney damage may be irreversible.

Exposure to sunlight for extended periods of time does not normally cause vitamin D toxicity.[82] This is because within about 20 minutes of ultraviolet exposure in light skinned individuals (3–6 times longer for pigmented skin) the concentrations of vitamin D precursors produced in the skin reach an Chemical equilibrium|equilibrium, and any further vitamin D that is produced is degraded.[86] According to some sources, endogenous production with full body exposure to sunlight is approximately 250 µg (10,000 IU) per day.[82] According to Holick, "the skin has a large capacity to produce cholecalciferol"; his experiments indicate that

"[W]hole-body exposure to one minimal erythemal dose of simulated solar ultraviolet radiation is comparable with taking an oral dose of between 250 and 625 micrograms (10 000 and 25 000 IU) vitamin D."[86]

The similar effect of supplementation and whole body exposure to one erythemal dose prompted a researcher [87] to suggest that 250 micrograms/day (10,000 IU) in healthy adults should be adopted as the tolerable upper limit.[87] Supplements and skin synthesis have a different effect on serum 25(OH)D concentrations;[88] endogenously synthesized vitamin D3 travels in plasma almost exclusively on vitamin D-binding protein (VDBP), providing for a slower hepatic delivery of the vitamin D and the more sustained increase in plasma 25-hydroxycholecalciferol. Orally administered vitamin D produces swift hepatic delivery and increases in plasma 25-hydroxycholecalciferol. The richest food source of vitamin D — wild salmon — would require 35 ounces a day to provide 10,000IU.[89] Recommending supplementation, when those supposedly in need of it are labeled healthy, has proved contentious, and doubt exists concerning long term effects of attaining and maintaining serum 25(OH)D of at least 80nmol/L by supplementation.[90]

A Toronto study concluded, "skin pigmentation, assessed by measuring skin melanin content, showed an inverse relationship with serum 25(OH)D". The uniform occurrence of low serum 25(OH)D in Indians living in India.[91] and Chinese in China,[92] does not support the hypothesis that the low levels seen in the more pigmented are due to lack of synthesis from the sun at higher latitudes; the leader of the study has urged dark-skinned immigrants to take vitamin D supplements nonetheless, saying, "I see no risk, no downside, there's only a potential benefit".[93][94] Whether the toxicity of oral intake of vitamin D is due to that route being unnatural, as suggested by Fraser,[88] is not known, but there is evidence to suggest that dietary vitamin D may be carried by lipoprotein particles[95] into cells of the artery wall and atherosclerotic plaque, where it may be converted to active form by monocyte-macrophages.[96] These findings raise questions regarding the effects of vitamin D intake on atherosclerotic calcification and cardiovascular risk.

Health effects

edit

Immune system

edit

VDR ligands have been shown to increase the activity of natural killer cells, and enhance the phagocytic activity of macrophages.[19] Active vitamin D hormone also increases the production of cathelicidin, an antimicrobial peptide that is produced in macrophages triggered by bacteria, viruses, and fungi.[97][98][99] Suggestions of a link between Vitamin D and the onset of multiple sclerosis posited that this is due to the immune-response suppression properties of Vitamin D[100] and that vitamin D is required to activate a histocompatibility gene (HLA-DRB1*1501) necessary for differentiating between self and foreign proteins in a subgroup of individuals genetically predisposed to MS.[101] Whether vitamin D supplements during pregnancy can lessen the likelihood of the child developing MS later in life is not known;[102][103] however, vitamin D fortification has been suggested to have caused a pandemic of allergic disease[104] and an association between vitamin D supplementation in infancy and an increased risk of atopy and allergic rhinitis later in life has been found .[105] Veteran vitamin D researcher Hector DeLuca has cast doubt on whether vitamin D affects MS.[106]

Influenza

edit

Lack of vitamin D synthesis is a possible explanation for high rates of influenza infection during winter; however, see flu season for the factors apart from vitamin D that are also hypothesized to influence rates of infection during winter. [107]

Cancer

edit

The molecular basis for thinking vitamin D has the potential to prevent cancer lies in its role in a wide range of cellular mechanisms central to the development of cancer.[108] These effects may be mediated through vitamin D receptors expressed in cancer cells.[19] Polymorphism (biology)|Polymorphisms of the vitamin D receptor (VDR) gene have been associated with an increased risk of breast cancer.[109] Women with mutations in the VDR gene had an increased risk of breast cancer.[110]

A 2006 study using data on over 4 million cancer patients from 13 different countries showed a marked increase in some cancer risks in countries with less sun and another Meta-analysis|metastudy found correlations between vitamin D levels and cancer. The authors suggested that intake of an additional 1,000 international units (IU) (or 25 micrograms) of vitamin D daily reduced an individual's colon cancer risk by 50%, and breast cancer|breast and ovarian cancer risks by 30%.[111][112][113][114] Low levels of vitamin D in serum have been correlated with breast cancer disease progression and bone metastases.[109] However, the vitamin D levels of a population do not depend on the solar irradiance to which they are exposed.[115][116][117][118] Moreover there are genetic factors involved with cancer incidence and mortality which are more common in northern latitudes.[119][120]

A 2006 study found that taking the U.S. RDA of vitamin D (400 IU per day) cut the risk of pancreatic cancer by 43% in a sample of more than 120,000 people from two long-term health surveys.[121][122] However, in male smokers a 3-fold increased risk for pancreatic cancer in the highest compared to lowest quintile of serum 25-hydroxyvitamin D concentration has been found.[123]

A randomized intervention study involving 1,200 women, published in June 2007, reports that vitamin D supplementation (1,100 international units (IU)/day) resulted in a 60% reduction in cancer incidence, during a four-year clinical trial, rising to a 77% reduction for cancers diagnosed after the first year (and therefore excluding those cancers more likely to have originated prior to the vitamin D intervention).[124][125] Although the study was criticized on several grounds[126] including failing to take into account a long term overall increase in cancer found in a another study of vitamin D intake[127] in 2007 the Canadian Cancer Society, (a national community-based organization of volunteers) recommended that all adults begin taking 1,000 IU per day (five times more than the government says they need) .[128][129] A US National Cancer Institute study analyzed data from the third national Health and Nutrition Examination Survey to examine the relationship between levels of circulating vitamin D in the blood and cancer mortality in a group of 16,818 participants aged 17 and older. It found no support for an association between 25(OH)D and total cancer mortality.[130] Unlike other studies, this one was carried out prospective cohort study|prospectively, meaning that participants were followed looking forward, and the researchers used actual blood tests to measure the amount of vitamin D in blood, rather than trying to infer vitamin D levels from potentially inaccurate predictive models.[118][131]

Cardiovascular disease

edit

A report from the National Health and Nutrition Examination Survey (NHANES) involving nearly 5,000 participants found that low levels of vitamin D were associated with an increased risk of peripheral artery disease (PAD). The incidence of PAD was 80% higher in participants with the lowest vitamin D levels (<17.8 ng/mL).[70] Cholesterol levels were found to be reduced in gardeners in the UK during the summer months.[132] Low levels of vitamin D are associated with an increase in high blood pressure and cardiovascular risk. Numerous observational study|observational studies show this link, but of two systemic reviews one found only weak evidence of benefit from supplements and the other found no evidence of a beneficial effect whatsoever.[133][134][135]

There is a certain amount of evidence to suggest that dietary vitamin D may be carried by lipoprotein particles[95] into cells of the artery wall and atherosclerotic plaque, where it may be converted to active form by monocyte-macrophages.[96] These findings raise questions regarding the effects of vitamin D intake on atherosclerotic calcification and cardiovascular risk. Calcifediol (25-hydroxy-vitamin D) is implicated in the etiology of atherosclerosis, especially in non-Caucasians.[88][90][136][137] Freedman et al. (2010) have found that serum vitamin D correlates in African Americans, but not in Euro-Americans, with calcified atheroscleratic plaque. "Higher levels of 25-hydroxyvitamin D seem to be positively correlated with aorta and carotid CP in African Americans but not with coronary CP. These results contradict what is observed in individuals of European descent".[90][137][116][138][117] One study found an elevated risk of ischaemic heart disease in Southern India in individuals whose vitamin D levels were above 89 ng/mL.[136] A review of vitamin D status in India concluded that studies uniformly point to low 25(OH)D levels in Indians despite abundant sunshine, and suggested a public health need to fortify Indian foods with vitamin D might exist.[139] However the levels found in India are consistent with many other studies of tropical populations which have found that even an extreme amount of sun exposure, such as incured by rural Indians,[140] does not raise 25(OH)D levels to the levels typically found in Europeans,[141][142][115]

Mortality

edit

Using information from the National Health and Nutrition Examination Survey a group of researchers concluded that having low levels of vitamin D (<17.8 ng/ml) was independently associated with an increase in all-cause mortality in the general population.[143] The study evaluated whether low serum vitamin D levels were associated with all-cause mortality, cancer, and cardiovascular disease (CVD) mortality among 13,331 diverse American adults who were 20 years or older. Vitamin D levels of these participants were collected over a 6-year period (from 1988 through 1994), and individuals were passively followed for mortality through the year 2000. Shortening of leukocyte telomeres is a marker of aging. Leukocyte telomere length (LTL) predicts the development of aging-related disease, and length of these telomeres decreases with each cell division and with increased inflammation (more common in the elderly). Vitamin D can inhibit proinflammatory overeaction and slow the turnover of leukocytes, longer leukocyte telomere length is achieved by the body maintaining the optimal vitamin D concentration.[144]

Complex regulatory mechanisms control metabolism, recent epidemiologic evidence suggests that there is a narrow range of vitamin D levels in which vascular function is optimized. Levels above or below this natural human homeostasis|homeostasis of vitamin D increase mortality.[96] Overall, excess or deficiency in the calcipherol system appear to cause abnormal functioning and premature aging.[145][146][147]

Mental health

edit

Vitamin D deficiency may also play a role in depression and other psychological issues. Though some research has been conducted which indicates a relationship, much more research is needed in this area.[148][149]


Vitamin D is involved in normal hair growth. [150]

See also

edit

References

edit
  1. Walter F., PhD. Boron (2003). "The Parathyroid Glands and Vitamin F". Medical Physiology: A Cellular And Molecular Approaoch. Elsevier/Saunders. p. 1094. ISBN 978-1-4160-2328-9.
  2. Institute of Medicine (IOM). Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride (1997) Access date: 2010-04-14 [1]
  3. Adams, JS; Hewison, M (2010). "Update in vitamin D". J Clin Endocrinol Metab. 95 (2): 471–8. doi:10.1210/jc.2009-1773. PMC 2840860. PMID 20133466. {{cite journal}}: Unknown parameter |month= ignored (help)
  4. a b c "Dietary Supplement Fact Sheet: Vitamin D". National Institutes of Health Office of Dietary Spplements. Retrieved 2010-04-11.
  5. Dorland's Illustrated Medical Dictionary, under Vitamin (Table of Vitamins)
  6. History of Vitamin D University of California, Riverside, Vitamin D Workshop.
  7. a b c About Vitamin D Including Sections: History, Nutrition, Chemistry, Biochemistry, and Diseases. University of California Riverside
  8. a b Holick, MF (2004). "Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis". The American journal of clinical nutrition. 79 (3): 362–71. PMID 14985208.
  9. Crissey, SD; Ange, KD; Jacobsen, KL; Slifka, KA; Bowen, PE; Stacewicz-Sapuntzakis, M; Langman, CB; Sadler, W; Kahn, S (2003). "Serum concentrations of lipids, vitamin d metabolites, retinol, retinyl esters, tocopherols and selected carotenoids in twelve captive wild felid species at four zoos". The Journal of nutrition. 133 (1): 160–6. PMID 12514284.
  10. Yahav, S; Buffenstein, R (1993). "Cholecalciferol supplementation alters gut function and improves digestibility in an underground inhabitant, the naked mole rat (Heterocephalus glaber), when fed on a carrot diet". The British journal of nutrition. 69 (1): 233–41. doi:10.1079/BJN19930025. PMID 8384476.
  11. Csiszar, A; Labinskyy, N; Orosz, Z; Xiangmin, Z; Buffenstein, R; Ungvari, Z (2007). "Vascular aging in the longest-living rodent, the naked mole rat". American journal of physiology. Heart and circulatory physiology. 293 (2): H919–27. doi:10.1152/ajpheart.01287.2006. PMID 17468332.
  12. Buffenstein, R (2008). "Negligible senescence in the longest living rodent, the naked mole-rat: insights from a successfully aging species". Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology. 178 (4): 439–45. doi:10.1007/s00360-007-0237-5. PMID 18180931.
  13. Stout, Sam D.; Agarwal, Sabrina C.; Stout, Samuel D. (2003). Bone loss and osteoporosis: an anthropological perspective. New York: Kluwer Academic/Plenum Publishers. ISBN 0-306-47767-X.
  14. UNRAVELING THE ENIGMA OF VITAMIN D U.S. National Academy of Sciences
  15. "Windaus biography at". Nobelprize.org. 1959-06-09. Retrieved 2010-03-25.
  16. Manaseki-Holland, S. et al., 2008. Vitamin D status of socio-economically deprived children in Kabul, Afghanistan. International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift Für Vitamin- Und Ernährungsforschung. Journal International De Vitaminologie Et De Nutrition, 78(1), 16-20.
  17. Stellinga-Boelen, A.A.M. et al., 2007. Vitamin D levels in children of asylum seekers in The Netherlands in relation to season and dietary intake. European Journal of Pediatrics, 166(3), 201-206.
  18. a b c Holick, MF (2004). "Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease". The American journal of clinical nutrition. 80 (6 Suppl): 1678S–88S. PMID 15585788.
  19. a b c Vitamin D The Physicians Desk Reference. 2006 Thompson Healthcare.
  20. Bijlsma, MF; Spek, CA; Zivkovic, D; Van De Water, S; Rezaee, F; Peppelenbosch, MP (2006). "Repression of smoothened by patched-dependent (pro-)vitamin D3 secretion". PLoS biology. 4 (8): e232. doi:10.1371/journal.pbio.0040232. PMC 1502141. PMID 16895439.
  21. "Hedgehog signaling and Vitamin D". Medscape.com. 2009-12-18. Retrieved 2010-03-25.
  22. Nowson, CA; Margerison, C (2002). "Vitamin D intake and vitamin D status of Australians". The Medical journal of Australia. 177 (3): 149–52. PMID 12149085.
  23. Holick, Michael (May 2007). "The Vitamin D Pandemic and its Health Consequences". 34th European Symposium on Calcified Tissues. Copenhagen. http://www.uvadvantage.org/portals/0/pres/. Retrieved 2010-03-29. 
  24. "Dietary Supplement Fact Sheet: Vitamin D". Ods.od.nih.gov. Retrieved 2010-03-25.
  25. "Dietary Reference Intakes for Vitamin D and Calcium". Iom.edu. Retrieved 2010-03-25.
  26. "Over and undernutrition: challenges and approaches". Proceedings of the Nutrition Society. 69.
  27. Manaseki-Holland, S. et al., 2008. Vitamin D status of socio-economically deprived children in Kabul, Afghanistan. International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift Für Vitamin- Und Ernährungsforschung. Journal International De Vitaminologie Et De Nutrition, 78(1), 16-20.
  28. "Relative contributions of different food groups to vitamin D intake in Asian and Caucasian UK women: results from the Vitamin D". Proceedings of the Nutrition Society. 69.
  29. "If mushrooms see the light — Los Angeles Times". Articles.latimes.com. 2008-03-31. Retrieved 2010-03-25.
  30. Koyyalamudi, SR; Jeong, SC; Song, CH; Cho, KY; Pang, G (2009). "Vitamin D2 formation and bioavailability from Agaricus bisporus button mushrooms treated with ultraviolet irradiation". Journal of agricultural and food chemistry. 57 (8): 3351–5. doi:10.1021/jf803908q. PMID 19281276.
  31. a b Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride(1997)., ISBN 978-0-309-06350-0. [2] page 235 [3]
  32. Jones, G (2008). "Pharmacokinetics of vitamin D toxicity". The American journal of clinical nutrition. 88 (2): 582S–586S. PMID 18689406.
  33. Lucas, JA; Bolland, MJ; Grey, AB; Ames, RW; Mason, BH; Horne, AM; Gamble, GD; Reid, IR (2005). "Determinants of vitamin D status in older women living in a subtropical climate". Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 16 (12): 1641–8. doi:10.1007/s00198-005-1888-2. PMID 16027959.
  34. Bolland, MJ; Grey, AB; Ames, RW; Mason, BH; Horne, AM; Gamble, GD; Reid, IR (2006). "Determinants of vitamin D status in older men living in a subtropical climate". Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 17 (12): 1742–8. doi:10.1007/s00198-006-0190-2. PMID 16932872.
  35. Field, AE; Coakley, EH; Must, A; Spadano, JL; Laird, N; Dietz, WH; Rimm, E; Colditz, GA (2001). "Impact of overweight on the risk of developing common chronic diseases during a 10-year period". Archives of internal medicine. 161 (13): 1581–6. doi:10.1001/archinte.161.13.1581. PMID 11434789.
  36. Wortsman, J; Matsuoka, LY; Chen, TC; Lu, Z; Holick, MF (2000). "Decreased bioavailability of vitamin D in obesity". The American journal of clinical nutrition. 72 (3): 690–3. PMID 10966885.
  37. Scientific Advisory Committee on Nutrition (2007) Update on Vitamin D Position Statement by the Scientific Advisory Committee on Nutrition 2007 ISBN 9780112431145
  38. Office of Dietary Supplements • National Institutes of Health Dietary Supplement Fact Sheet: Vitamin D [4]
  39. a b Pittas, AG; Chung, M; Trikalinos, T; Mitri, J; Brendel, M; Patel, K; Lichtenstein, AH; Lau, J; Balk, EM (2010). "Systematic review: Vitamin D and cardiometabolic outcomes". Annals of internal medicine. 152 (5): 307–14. doi:10.1059/0003-4819-152-5-201003020-00009. PMID 20194237. {{cite journal}}: Unknown parameter |doi_brokendate= ignored (|doi-broken-date= suggested) (help)
  40. Wang, L; Manson, JE; Song, Y; Sesso, HD (2010). "Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events". Annals of internal medicine. 152 (5): 315–23. doi:10.1059/0003-4819-152-5-201003020-00010. PMID 20194238. {{cite journal}}: Unknown parameter |doi_brokendate= ignored (|doi-broken-date= suggested) (help)
  41. Binkley, N; Novotny, R; Krueger, D; Kawahara, T; Daida, YG; Lensmeyer, G; Hollis, BW; Drezner, MK (2007). "Low vitamin D status despite abundant sun exposure". The Journal of clinical endocrinology and metabolism. 92 (6): 2130–5. doi:10.1210/jc.2006-2250. PMID 17426097.
  42. a b Hollis, BW; Wagner, CL; Drezner, MK; Binkley, NC (2007). "Circulating vitamin D3 and 25-hydroxyvitamin D in humans: An important tool to define adequate nutritional vitamin D status". The Journal of steroid biochemistry and molecular biology. 103 (3–5): 631–4. doi:10.1016/j.jsbmb.2006.12.066. PMC 1868557. PMID 17218096.
  43. [5] Vitamin D at Merck Manual of Diagnosis and Therapy Professional Edition]
  44. Schoenmakers, I; Goldberg, GR; Prentice, A (2008). "Abundant sunshine and vitamin D deficiency". The British journal of nutrition. 99 (6): 1171–3. doi:10.1017/S0007114508898662. PMC 2758994. PMID 18234141.
  45. Grant, WB; Holick, MF (2005). "Benefits and requirements of vitamin D for optimal health: a review". Alternative medicine review. 10 (2): 94–111. PMID 15989379.
  46. Lerch, C; Meissner, T; Lerch, Christian (2007). "Interventions for the prevention of nutritional rickets in term born children". Cochrane database of systematic reviews (Online) (4): CD006164. doi:10.1002/14651858.CD006164.pub2. PMID 17943890.
  47. Zargar, A. H.; Mithal, A; Wani, AI; Laway, BA; Masoodi, SR; Bashir, MI; Ganie, MA (2000). "Pseudovitamin D deficiency rickets---a report from the Indian subcontinent". Postgraduate Medical Journal. 76 (896): 369. doi:10.1136/pmj.76.896.369. PMC 1741602. PMID 10824056.
  48. Gibbs, D (1994). "Rickets and the crippled child: an historical perspective". Journal of the Royal Society of Medicine. 87 (12): 729–32. PMC 1294978. PMID 7503834.
  49. Dunnigan, M (2003). "Commentary: John Snow and alum-induced rickets from adulterated London bread: an overlooked contribution to metabolic bone disease". International journal of epidemiology. 32 (3): 340–1. doi:10.1093/ije/dyg160. PMID 12777415.
  50. Pileggi, V; De Luca, HF; Steenbock, H (1955). "The role of vitamin D and intestinal phytase in the prevention of rickets in rats on cereal diets*1". Archives of Biochemistry and Biophysics. 58 (1): 194. doi:10.1016/0003-9861(55)90106-5. PMID 13259690.
  51. Ford, JA; Colhoun, EM; McIntosh, WB; Dunnigan, MG (1972). "Biochemical response of late rickets and osteomalacia to a chupatty-free diet". British medical journal. 3 (5824): 446–7. doi:10.1136/bmj.3.5824.446. PMC 1786011. PMID 5069221.
  52. Rajakumar, K (2003). "Vitamin D, cod-liver oil, sunlight, and rickets: a historical perspective". Pediatrics. 112 (2): e132–5. doi:10.1542/peds.112.2.e132. PMID 12897318.
  53. Oramasionwu, GE; Thacher, TD; Pam, SD; Pettifor, JM; Abrams, SA (2008). "Adaptation of calcium absorption during treatment of nutritional rickets in Nigerian children". The British journal of nutrition. 100 (2): 387–92. doi:10.1017/S0007114507901233. PMID 18197991.
  54. Fischer, PR; Rahman, A; Cimma, JP; Kyaw-Myint, TO; Kabir, AR; Talukder, K; Hassan, N; Manaster, BJ; Staab, DB (1999). "Nutritional rickets without vitamin D deficiency in Bangladesh". Journal of tropical pediatrics. 45 (5): 291–3. doi:10.1093/tropej/45.5.291. PMID 10584471.
  55. Dunnigan, MG; Henderson, JB (1997). "An epidemiological model of privational rickets and osteomalacia". The Proceedings of the Nutrition Society. 56 (3): 939–56. PMID 9483661.
  56. Robertson, I; Ford, JA; McIntosh, WB; Dunnigan, MG (1981). "The role of cereals in the aetiology of nutritional rickets: the lesson of the Irish National Nutrition Survey 1943-8". The British journal of nutrition. 45 (1): 17–22. doi:10.1079/BJN19810073. PMID 6970590.
  57. Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1111/j.1365-277X.1989.tb00015.x, please use {{cite journal}} with |doi=10.1111/j.1365-277X.1989.tb00015.x instead.
  58. Pettifor, JM (2004). "Nutritional rickets: deficiency of vitamin D, calcium, or both?". The American journal of clinical nutrition. 80 (6 Suppl): 1725S–9S. PMID 15585795.
  59. Dunnigan, MG; Henderson, JB (1997). "An epidemiological model of privational rickets and osteomalacia". The Proceedings of the Nutrition Society. 56 (3): 939–56. PMID 9483661.
  60. a b Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1079/BJN20051558, please use {{cite journal}} with |doi=10.1079/BJN20051558 instead.
  61. Pettifor, JM (2004). "Nutritional rickets: deficiency of vitamin D, calcium, or both?". The American journal of clinical nutrition. 80 (6 Suppl): 1725S–9S. PMID 15585795.
  62. US National Institutes Of Health, National cancer Institute
  63. Weick, MT (1967). "A history of rickets in the United States". The American journal of clinical nutrition. 20 (11): 1234–41. PMID 4862158.
  64. Garrison, R., Jr., Somer, E., The nutrition desk reference(1997)
  65. E. Melanie DuPuis., Nature's Perfect Food: How Milk Became America's Drink(2002) ISBN 978-0814719381
  66. Teegarden, D; Lyle, RM; Proulx, WR; Johnston, CC; Weaver, CM (1999). "Previous milk consumption is associated with greater bone density in young women". The American journal of clinical nutrition. 69 (5): 1014–7. PMID 10232644.
  67. Holick, MF (2003). "Vitamin D: A millenium perspective". Journal of cellular biochemistry. 88 (2): 296–307. doi:10.1002/jcb.10338. PMID 12520530.
  68. Stewart B. Leavitt. "Vitamin D – A Neglected 'Analgesic' for Chronic Musculoskeletal Pain" (PDF). Pain-Topics.org. Retrieved 2009-03-25.
  69. Straube, S; Andrew Moore, R; Derry, S; McQuay, HJ (2009). "Vitamin D and chronic pain". Pain. 141 (1–2): 10–3. doi:10.1016/j.pain.2008.11.010. PMID 19084336.
  70. a b Melamed, ML; Muntner, P; Michos, ED; Uribarri, J; Weber, C; Sharma, J; Raggi, P (2008). "Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004". Arteriosclerosis, thrombosis, and vascular biology. 28 (6): 1179–85. doi:10.1161/ATVBAHA.108.165886. PMC 2705139. PMID 18417640.
  71. Tavera-Mendoza, LE; White, JH (2007). "Cell defenses and the sunshine vitamin". Scientific American. 297 (5): 62–5, 68–70, 72. doi:10.1038/scientificamerican1107-62. PMID 17990825.
  72. Evatt, ML; Delong, MR; Khazai, N; Rosen, A; Triche, S; Tangpricha, V (2008). "Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease". Archives of neurology. 65 (10): 1348–52. doi:10.1001/archneur.65.10.1348. PMC 2746037. PMID 18852350.
  73. Holick., M., The Vitamin D Solution: A 3- Step Strategy to Cure Our Most Common Health Problem (2010) ISBN 1594630674
  74. Lee, J; Okeefe, J; Bell, D; Hensrud, D; Holick, M (2008). "Vitamin D DeficiencyAn Important, Common, and Easily Treatable Cardiovascular Risk Factor?". Journal of the American College of Cardiology. 52 (24): 1949. doi:10.1016/j.jacc.2008.08.050. PMID 19055985.
  75. O'Keefe, James H.; Lee, John H.; Bell, David S. H.; Holick, Michael F. (2009). "Reply". Journal of the American College of Cardiology. 53: 2012. doi:10.1016/j.jacc.2009.02.031.
  76. Jacobs, ET; Alberts, DS; Foote, JA; Green, SB; Hollis, BW; Yu, Z; Martínez, ME (2008). "Vitamin D insufficiency in southern Arizona". The American journal of clinical nutrition. 87 (3): 608–13. PMID 18326598.
  77. Binkley, N.; Novotny, R.; Krueger, D.; Kawahara, T.; Daida, Y. G.; Lensmeyer, G.; Hollis, B. W.; Drezner, M. K. (2007). "Low Vitamin D Status despite Abundant Sun Exposure". Journal of Clinical Endocrinology & Metabolism. 92: 2130. doi:10.1210/jc.2006-2250.
  78. Bischoff-Ferrari, HA; Giovannucci, E; Willett, WC; Dietrich, T; Dawson-Hughes, B (2006). "Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes". The American journal of clinical nutrition. 84 (1): 18–28. PMID 16825677.
  79. Mozaffarian, Dariush (2009). "Vitamin D, Outdoor Happiness, and the Meaning of Deficiency". Journal of the American College of Cardiology. 53: 2011. doi:10.1016/j.jacc.2008.12.070.
  80. Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1038/jid.2009.353, please use {{cite journal}} with |doi=10.1038/jid.2009.353 instead.
  81. Vitamin D. The Merck Manuals Vitamin D
  82. a b c Vieth R (1999). "Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety". The American Journal of Clinical Nutrition. 69 (5): 842–56. PMID 10232622. {{cite journal}}: Unknown parameter |month= ignored (help)
  83. [6] European Food and Safety authority., Tolerable Upper Intake Limits for Vitamins And Minerals(2006) ISBN 92-9199-014-0
  84. Vitamin D at Merck Manual of Diagnosis and Therapy Professional Edition
  85. Vitamin D - Toxicity at Merck Manual of Diagnosis and Therapy Professional Edition
  86. a b Holick MF (1995). "Environmental factors that influence the cutaneous production of vitamin D". The American Journal of Clinical Nutrition. 61 (3 Suppl): 638S–645S. PMID 7879731. {{cite journal}}: Unknown parameter |month= ignored (help)
  87. a b Hathcock JN, Shao A, Vieth R, Heaney R (2007). "Risk assessment for vitamin D". The American Journal of Clinical Nutrition. 85 (1): 6–18. PMID 17209171. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  88. a b c Haddad JG, Matsuoka LY, Hollis BW, Hu YZ, Wortsman J (1993). "Human plasma transport of vitamin D after its endogenous synthesis". The Journal of Clinical Investigation. 91 (6): 2552–5. doi:10.1172/JCI116492. PMC 443317. PMID 8390483. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  89. Lu Z, Chen TC, Zhang A; et al. (2007). "An evaluation of the vitamin D3 content in fish: Is the vitamin D content adequate to satisfy the dietary requirement for vitamin D?". The Journal of Steroid Biochemistry and Molecular Biology. 103 (3–5): 642–4. doi:10.1016/j.jsbmb.2006.12.010. PMC 2698592. PMID 17267210. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  90. a b c Tseng, Lisa (2003). "Controversies in Vitamin D Supplementation". Nutrition Bytes. 9 (1).
  91. Harinarayan, CV; Joshi, SR (2009). "Vitamin D status in India--its implications and remedial measures". The Journal of the Association of Physicians of India. 57: 40–8. PMID 19753759.
  92. Lips, P (2010). "Worldwide status of vitamin D nutrition". The Journal of steroid biochemistry and molecular biology. doi:10.1016/j.jsbmb.2010.02.021. PMID 20197091.
  93. CBC Dark-skinned immigrants urged to take vitamin D Tuesday, February 16, 2010 CBC news
  94. STEPHEN STRAUSS: SCIENCE FRICTION The vitamin D debate Feb. 13, 2008 [7] CBC Analysis and viewpoint
  95. a b Speeckaert MM, Taes YE, De Buyzere ML, Christophe AB, Kaufman JM, Delanghe JR (2010). "Investigation of the potential association of vitamin D binding protein with lipoproteins". Annals of Clinical Biochemistry. 47 (2): 143–50. doi:10.1258/acb.2009.009018. PMID 20144976. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  96. a b c Hsu JJ, Tintut Y, Demer LL (2008). "Vitamin D and osteogenic differentiation in the artery wall". Clinical Journal of the American Society of Nephrology. 3 (5): 1542–7. doi:10.2215/CJN.01220308. PMID 18562594. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  97. Janet Raloff, The Antibiotic Vitamin Science News, Vol 170, November 11, 2006, pages 312-317
  98. Martineau, AR; Wilkinson, RJ; Wilkinson, KA; Newton, SM; Kampmann, B; Hall, BM; Packe, GE; Davidson, RN; Eldridge, SM (2007). "A single dose of vitamin D enhances immunity to mycobacteria". American journal of respiratory and critical care medicine. 176 (2): 208–13. doi:10.1164/rccm.200701-007OC. PMID 17463418.
  99. Muhe, L; Lulseged, S; Mason, KE; Simoes, EA (1997). "Case-control study of the role of nutritional rickets in the risk of developing pneumonia in Ethiopian children". Lancet. 349 (9068): 1801–4. doi:10.1016/S0140-6736(96)12098-5. PMID 9269215.
  100. Munger, KL; Levin, LI; Hollis, BW; Howard, NS; Ascherio, A (2006). "Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis". JAMA. 296 (23): 2832–8. doi:10.1001/jama.296.23.2832. PMID 17179460.
  101. "Science News / Molecular Link Between Vitamin D Deficiency And MS". Retrieved 2009-02-25.
  102. "Vitamin D helps control MS gene". BBC News. 5 February 2009. http://news.bbc.co.uk/2/hi/health/7871598.stm. Retrieved 2010-03-25. 
  103. "Genetic Study Supports Vitamin D Deficiency as an Environmental Factor in MS Susceptibility. Multiple Sclerosis Society of Canada. 5 February 2009". Mssociety.ca. Retrieved 2010-03-25.
  104. Wjst, M (2009). "Introduction of oral vitamin D supplementation and the rise of the allergy pandemic". Allergy, asthma, and clinical immunology. 5 (1): 8. doi:10.1186/1710-1492-5-8. PMC 2794851. PMID 20016691.
  105. Hyppönen, E; Sovio, U; Wjst, M; Patel, S; Pekkanen, J; Hartikainen, AL; Järvelinb, MR (2004). "Infant vitamin d supplementation and allergic conditions in adulthood: northern Finland birth cohort 1966". Annals of the New York Academy of Sciences. 1037: 84–95. doi:10.1196/annals.1337.013. PMID 15699498.
  106. Becklund, B. R.; Severson, K. S.; Vang, S. V.; Deluca, H. F. (2010). "UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production". Proceedings of the National Academy of Sciences. 107: 6418. doi:10.1073/pnas.1001119107.
  107. Lowen, Anice C. (2007). "Influenza virus transmission is dependent on relative humidity and temperature". PLoS Pathogens. 3 (10): e151. doi:10.1371/journal.ppat.0030151. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)
  108. Ingraham, BA; Bragdon, B; Nohe, A (2008). "Molecular basis of the potential of vitamin D to prevent cancer". Current medical research and opinion. 24 (1): 139–49. doi:10.1185/030079908X253519. PMID 18034918.
  109. a b Buyru, N; Tezol, A; Yosunkaya-Fenerci, E; Dalay, N (2003). "Vitamin D receptor gene polymorphisms in breast cancer". Experimental & molecular medicine. 35 (6): 550–5. PMID 14749534.
  110. Chen WY, Bertone-Johnson ER, Hunter DJ, Walter Willett|Willett WC, Hankinson SE. Associations Between Polymorphisms in the Vitamin D Receptor and Breast Cancer Risk. Cancer Epidemiology, Biomarkers, & Prevention. 2005; 14(10):2335-2339.
  111. Garland, CF; Garland, FC; Gorham, ED; Lipkin, M; Newmark, H; Mohr, SB; Holick, MF (2006). "The role of vitamin D in cancer prevention". American journal of public health. 96 (2): 252–61. doi:10.2105/AJPH.2004.045260. PMC 1470481. PMID 16380576.
  112. "Vitamin D 'can lower cancer risk'". BBC News. 28 December 2005. http://news.bbc.co.uk/2/hi/health/4563336.stm. Retrieved 2006-03-23. 
  113. Gorham, ED; Garland, CF; Garland, FC; Grant, WB; Mohr, SB; Lipkin, M; Newmark, HL; Giovannucci, E; Wei, M (2007). "Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis". American journal of preventive medicine. 32 (3): 210–6. doi:10.1016/j.amepre.2006.11.004. PMID 17296473.
  114. Garland, CF; Mohr, SB; Gorham, ED; Grant, WB; Garland, FC (2006). "Role of ultraviolet B irradiance and vitamin D in prevention of ovarian cancer". American journal of preventive medicine. 31 (6): 512–4. doi:10.1016/j.amepre.2006.08.018. PMID 17169713.
  115. a b Hagenau, T; Vest, R; Gissel, TN; Poulsen, CS; Erlandsen, M; Mosekilde, L; Vestergaard, P (2009). "Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis". Osteoporosis international. 20 (1): 133–40. doi:10.1007/s00198-008-0626-y. PMID 18458986.
  116. a b Engelman, CD; Fingerlin, TE; Langefeld, CD; Hicks, PJ; Rich, SS; Wagenknecht, LE; Bowden, DW; Norris, JM (2008). "Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans". The Journal of clinical endocrinology and metabolism. 93 (9): 3381–8. doi:10.1210/jc.2007-2702. PMC 2567851. PMID 18593774.
  117. a b Borges, CR; Rehder, DS; Jarvis, JW; Schaab, MR; Oran, PE; Nelson, RW (2010). "Full-length characterization of proteins in human populations". Clinical chemistry. 56 (2): 202–11. doi:10.1373/clinchem.2009.134858. PMID 19926773.
  118. a b Millen, AE; Wactawski-Wende, J; Pettinger, M; Melamed, ML; Tylavsky, FA; Liu, S; Robbins, J; Lacroix, AZ; Leboff, MS (2010). "Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women: the Women's Health Initiative Calcium plus Vitamin D Clinical Trial". The American journal of clinical nutrition. doi:10.3945/ajcn.2009.28908. PMID 20219959.
  119. Helgadottir, H; Andersson, E; Villabona, L; Kanter, L; Van Der Zanden, H; Haasnoot, GW; Seliger, B; Bergfeldt, K; Hansson, J (2009). "The common Scandinavian human leucocyte antigen ancestral haplotype 62.1 as prognostic factor in patients with advanced malignant melanoma". Cancer immunology, immunotherapy : CII. 58 (10): 1599–608. doi:10.1007/s00262-009-0669-8. PMID 19214504.
  120. De Petris, L; Bergfeldt, K; Hising, C; Lundqvist, A; Tholander, B; Pisa, P; Van Der Zanden, HG; Masucci, G (2004). "Correlation between HLA-A2 gene frequency, latitude, ovarian and prostate cancer mortality rates". Medical oncology (Northwood, London, England). 21 (1): 49–52. doi:10.1385/MO:21:1:49. PMID 15034213.
  121. Skinner, HG; Michaud, DS; Giovannucci, E; Willett, WC; Colditz, GA; Fuchs, CS (2006). "Vitamin D intake and the risk for pancreatic cancer in two cohort studies". Cancer epidemiology, biomarkers & prevention. 15 (9): 1688–95. doi:10.1158/1055-9965.EPI-06-0206. PMID 16985031.
  122. "Health | Vitamin D 'slashes cancer risk'". BBC News. 2006-09-15. http://news.bbc.co.uk/2/hi/health/5334534.stm. Retrieved 2010-03-25. 
  123. Stolzenberg-Solomon, R. Z.; Vieth, R.; Azad, A.; Pietinen, P.; Taylor, P. R.; Virtamo, J.; Albanes, D. (2006). "A Prospective Nested Case-Control Study of Vitamin D Status and Pancreatic Cancer Risk in Male Smokers". Cancer Research. 66: 10213. doi:10.1158/0008-5472.CAN-06-1876.
  124. Martin Mittelstaedt (28 April 2007). "Vitamin D casts cancer prevention in new light". Global and Mail. Archived from the original on 2009-06-22. http://web.archive.org/web/20090622092244/http://www.theglobeandmail.com/life/article756975.ece. Retrieved 2007-04-28. 
  125. Lappe, JM; Travers-Gustafson, D; Davies, KM; Recker, RR; Heaney, RP (2007). "Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial". The American journal of clinical nutrition. 85 (6): 1586–91. PMID 17556697.
  126. Ojha, RP; Felini, MJ; Fischbach, LA (2007). "Vitamin D for cancer prevention: valid assertion or premature anointment?". The American journal of clinical nutrition. 86 (6): 1804–5, author reply 1805–6. PMID 18065602.
  127. Robien, K; Cutler, GJ; Lazovich, D (2007). "Vitamin D intake and breast cancer risk in postmenopausal women: the Iowa Women's Health Study". Cancer causes & control. 18 (7): 775–82. doi:10.1007/s10552-007-9020-x. PMID 17549593.
  128. "Canadian Cancer Society announces Vitamin D recommendation, 08 June 2007". Cancer.ca. Retrieved 2010-03-25.
  129. "Canadian Cancer Society recommends vitamin D. CTV.ca News Staff". Montreal.ctv.ca. Retrieved 2010-03-25.
  130. Freedman, DM; Looker, AC; Chang, SC; Graubard, BI (2007). "Prospective study of serum vitamin D and cancer mortality in the United States". Journal of the National Cancer Institute. 99 (21): 1594–602. doi:10.1093/jnci/djm204. PMID 17971526.
  131. Savage, L.; Widener, A. (2007). "Study Finds No Connection between Vitamin D and Overall Cancer Deaths". JNCI Journal of the National Cancer Institute. 99: 1561. doi:10.1093/jnci/djm235.
  132. Grimes, DS; Hindle, E; Dyer, T (1996). "Sunlight, cholesterol and coronary heart disease". QJM. 89 (8): 579–89. PMID 8935479.
  133. Pittas, AG; Chung, M; Trikalinos, T; Mitri, J; Brendel, M; Patel, K; Lichtenstein, AH; Lau, J; Balk, EM (2010). "Systematic review: Vitamin D and cardiometabolic outcomes". Annals of internal medicine. 152 (5): 307–14. doi:10.1059/0003-4819-152-5-201003020-00009. PMID 20194237. {{cite journal}}: Unknown parameter |doi_brokendate= ignored (|doi-broken-date= suggested) (help)
  134. Wang, L; Manson, JE; Song, Y; Sesso, HD (2010). "Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events". Annals of internal medicine. 152 (5): 315–23. doi:10.1059/0003-4819-152-5-201003020-00010. PMID 20194238. {{cite journal}}: Unknown parameter |doi_brokendate= ignored (|doi-broken-date= suggested) (help)
  135. Nemerovski, CW; Dorsch, MP; Simpson, RU; Bone, HG; Aaronson, KD; Bleske, BE (2009). "Vitamin D and cardiovascular disease". Pharmacotherapy. 29 (6): 691–708. doi:10.1592/phco.29.6.691. PMID 19476421.
  136. a b Rajasree, S; Rajpal, K; Kartha, CC; Sarma, PS; Kutty, VR; Iyer, CS; Girija, G (2001). "Serum 25-hydroxyvitamin D3 levels are elevated in South Indian patients with ischemic heart disease". European journal of epidemiology. 17 (6): 567–71. doi:10.1023/A:1014559600042. PMID 11949730.
  137. a b Freedman, BI; Wagenknecht, LE; Hairston, KG; Bowden, DW; Carr, JJ; Hightower, RC; Gordon, EJ; Xu, J; Langefeld, CD (2010). "Vitamin D, Adiposity, and Calcified Atherosclerotic Plaque in African-Americans". Journal of Clinical Endocrinology & Metabolism. 95: 1076. doi:10.1210/jc.2009-1797.
  138. Creemers, PC; Du Toit, ED; Kriel, J (1995). "DBP (vitamin D binding protein) and BF (properdin factor B) allele distribution in Namibian San and Khoi and in other South African populations". Gene geography. 9 (3): 185–9. PMID 8740896.
  139. Harinarayan, CV; Joshi, SR (2009). "Vitamin D status in India--its implications and remedial measures". The Journal of the Association of Physicians of India. 57: 40–8. PMID 19753759.
  140. Goswami, R; Kochupillai, N; Gupta, N; Goswami, D; Singh, N; Dudha, A (2008). "Presence of 25(OH) D deficiency in a rural North Indian village despite abundant sunshine". The Journal of the Association of Physicians of India. 56: 755–7. PMID 19263699.
  141. Lips, P (2010). "Worldwide status of vitamin D nutrition". The Journal of steroid biochemistry and molecular biology. doi:10.1016/j.jsbmb.2010.02.021. PMID 20197091.
  142. Schoenmakers, I; Goldberg, GR; Prentice, Ann (2008). "Abundant sunshine and vitamin D deficiency". British Journal of Nutrition. 99. doi:10.1017/S0007114508898662.
  143. Melamed ML, Michos ED, Post W, Astor B (2008). "25-hydroxyvitamin D levels and the risk of mortality in the general population". Archives of Internal Medicine. 168 (15): 1629–37. doi:10.1001/archinte.168.15.1629. PMC 2677029. PMID 18695076. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  144. Richards JB, Valdes AM, Gardner JP; et al. (2007). "Higher serum vitamin D concentrations are associated with longer leukocyte telomere length in women". The American Journal of Clinical Nutrition. 86 (5): 1420–5. PMC 2196219. PMID 17991655. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  145. Tuohimaa P (2009). "Vitamin D and aging". The Journal of Steroid Biochemistry and Molecular Biology. 114 (1–2): 78–84. doi:10.1016/j.jsbmb.2008.12.020. PMID 19444937. {{cite journal}}: Unknown parameter |month= ignored (help)
  146. Keisala T, Minasyan A, Lou YR; et al. (2009). "Premature aging in vitamin D receptor mutant mice". The Journal of Steroid Biochemistry and Molecular Biology. 115 (3–5): 91–7. doi:10.1016/j.jsbmb.2009.03.007. PMID 19500727. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  147. Tuohimaa P, Keisala T, Minasyan A, Cachat J, Kalueff A (2009). "Vitamin D, nervous system and aging". Psychoneuroendocrinology. 34 (Suppl 1): S278–86. doi:10.1016/j.psyneuen.2009.07.003. PMID 19660871. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  148. Vitamin D Council
  149. Web MD
  150. Does D matter? The role of vitamin D in hair disorders and hair follicle cycling. Dermatol Online J. 2010 Feb 15;16(2).
edit